While the absolute risk of aspiration is uncertain and likely low for most patients, case reports and observational studies have documented instances where unexpected gastric contents were found during intubation in patients taking GLP-1 medications who had appropriately fasted
This review highlights that given the robust preclinical evidence and high public interest, there is a critical need for well-designed human trials to assess the safety, efficacy, and clinical utility of BPC-157 in musculoskeletal medicine
Should be administered Intravenously (IV) by a doctor, nurse or IV therapist
Follow-up is an important part of safe and responsible care
Innovative Encapsulation Technology: Encapsulation preserves NMN's full potency, allowing it to absorb effectively and maximize its firming, plumping, and skin-elasticity benefits
doi:10.1136/pgmj.56.657.459